CLINICAL_TRIALS trial_result · 2013-05-14

Clinical Trial Update: Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 2]

Summary

A Phase 2 trial assessed bevacizumab in patients with relapsed or refractory chronic lymphocytic leukemia; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2013-05-14